Cell lines and animals

KU Keiji Uchiyama
MT Mitsuru Tomita
MY Masashi Yano
JC Junji Chida
HH Hideyuki Hara
ND Nandita Rani Das
AN Anders Nykjaer
SS Suehiro Sakaguchi
request Request a Protocol
ask Ask a question
Favorite

Cells were maintained at 37°C with 5% CO2 in air in Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (FBS). N2aC24, N2aC24L1-3, and cured N2aC24L1-3 cells were previously established elsewhere [26]. N2aC24 cells were cloned from mouse neuroblastoma N2a cells overexpressing exogenous mouse PrPC. N2aC24L1-3 cells were cloned from N2aC24 cells persistently infected with 22L scrapie prions. Cured N2aC24L1-3 cells are cured from prion infection by treatment with SAF32 anti-PrP Ab and then maintained in antibody-free DMEM with 10% FBS. ScN2a cells (kindly gifted from Prof Doh-ura, Tohoku University) were N2a cells persistently infected with RML scrapie prions.

Sortilin-KO cells, ΔSort#1 and #2 cells, were established using the CRISPR-Cas genome editing system. N2aC24 cells were transduced with pRGEN-Cas9-CMV (Takara bio, Shiga, Japan) and pRGEN_Mouse-Sort1_U6_SG_1 targeting the sequence (5’-cctgccgccgtcggccaggaccg-3’) (Takara bio), and subjected to limiting dilution cloning. Knockout of sortilin in ΔSort#1 and #2 cells was confirmed by Western blotting.

PrP-KO N2a cells, termed N2aΔPrP cells, were also established using the CRISPR-Cas genome editing system. N2a cells were transduced with pRGEN-Cas9-CMV (Takara bio) and pRGEN_PrP_U6_SG_1 targeting the sequence (5’-accggtggaagccggtatcccgg-3’) (Takara bio), and subjected to limiting dilution cloning. Knockout of PrPC in N2aΔPrP cells was confirmed by Western blotting. To clone N2aΔPrP cells expressing full-length wild-type PrPC or PrPΔ23–88, pEF1-moPrP(3F4) and pEF1-moPrP(3F4)Δ23–88 were linearized by Sca I and transfected into N2aΔPrP cells. The cells were treated with G418 and the G418-resistant cells were cloned by limiting dilution, resulting in establishment WT#1 and #2 cells and Δ23–88#1 and #2 cells.

Sortilin-KO (Sort1-/-) mice used in this study were previously produced elsewhere [11,22]. Sort1-/- mice having been backcrossed for 10 generations into C57BL/6 were intercrossed with C57BL/6 mice (Charles River Laboratories, Kanagawa, Japan), and the resulting heterozygous mice (Sort-/+) were then intercrossed to obtain Sort-/- and wild-type (Sort+/+) mice.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A